| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |